The 2011 Frost & Sullivan Europe New Product Innovation Award in Dermatological Active Ingredients is presented to Mibelle Biochemistry for its intelligent cell protecting factor, SunActin.
"SunActin is an active ingredient designed to complement sun care products, as it can counteract the negative effects of UVA and UVB radiation as well as the negative side effects of sunscreens, while additionally protecting the skin," notes Frost & Sullivan Research Analyst Vin Nee.
SunActin is set to make strong gains as awareness about the need for sun protection and early prevention of ageing among both male and female populations rises. Furthermore, market trends are moving towards natural-derived product platforms, such as those offered by SunActin.
The dual benefits of sun protection and anti-ageing, have underlined its appeal. This unique product can be used in personal care product formulations for both young and mature consumers.
"SunActin, with potential sun protection and anti-ageing features, is proven by both in vitro and in vivo studies," remarks Nee. "The incorporation of SunActin into the product formulation of sunscreens exhibits enhancement of the protective effect of sunscreens in vivo. The ex vivo studies of SunActin treatment reveal its ability to boost the skin's defence capacity and protect it from UV induced oxidative stress through DNA microarray screening."
SunActin's anti-ageing property works by energising the skin cells and delaying ageing mechanisms. At the same time, it exerts skin protection in the sunscreen by radical scavenging properties and by enhancing SPF levels.
SunActin is derived from a combination of organic sunflower sprouts and a nanoemulsion of natural tocopherol. The sunflower shoot extract is carefully purified to be compatible with the nanoemulsion to ensure the product's stability and optimal delivery of the active ingredients to the skin structure.
"Strategic product positioning in accordance with the company's motto of ‘inspired by nature- realized by science' has enabled Mibelle Biochemistry to forge a new path in the field of dermatological active ingredients," concludes Nee. "Such efforts, as exemplified by SunActin, make Mibelle Biochemistry an obvious choice for this Frost & Sullivan accolade."
The New Product Innovation Award is presented to the company that has excelled in the following criteria: innovative element of the product, leverage leading edge technologies in product, value added features/benefits, increased customer ROI (small change) and customer acquisition/penetration potential.
Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.
About Mibelle Biochemistry
Mibelle Biochemistry (mibellebiochemistry.com), a Swiss company, is specialized in the research and development of innovative, high-quality actives for the cosmetic industry. Inspired by nature Mibelle Biochemistry transforms naturally derived compounds into truly functional cosmetic ingredients. Furthermore Mibelle Biochemistry possesses powerful encapsulation technologies that guarantee optimum bioavailability. All products are accompanied by comprehensive technical support and marketing-oriented documentation.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.